By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today said that it has acquired Bioline, a manufacturer and distributor of molecular biology reagents, for $23.3 million in cash on hand.

The acquisition pushes the Cincinnati-based diagnostics firm further into the molecular biology research products and molecular diagnostics fields. It also will provide products to complement the portfolio of its life science business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.